These findings suggested that SMYAD can improve the pathological changes of atherosclerosis and inhibit lipid deposition in ApoE-/- mice, which was associated with the inhibition of the differentiation and recruitment of monocytes and macrophages, the promotion of the differentiation and recruitment of Tregs, and the reduction of the secretion of pro-inflammatory factors (97). Here, APOE is linked to atherosclerosis.